Colombian Physician Makes History in the United States: Dr. Cesar Velilla Develops the World's First Healthcare Platform Built 100% with Artificial Intelligence

FOR IMMEDIATE RELEASE
Contact: MDGeniusAI Media Relations | press@mdgeniusai.com | (305) 831-1120

Colombian Physician Makes History in the United States:
Dr. Cesar Velilla Develops the World's First Healthcare Platform Built 100% with Artificial Intelligence
Colombian Cosmetic Surgeon, Harvard-Trained AI Specialist, and Serial Entrepreneur Leads Technological Revolution from Miami with MDGeniusAI - A Platform That Promises to Save Lives Through Early Detection of Surgical Complications

MIAMI, FL - December 2024 - In an achievement that fills the Latino community in the United States with pride, Dr. Cesar Velilla, a Colombian physician based in Miami, has announced the development of MDGeniusAI-the world's first healthcare technology platform built entirely with artificial intelligence from its conception. This historic milestone positions a Latin American professional at the forefront of the AI revolution in the healthcare sector.

Dr. Velilla, who emigrated from Colombia to pursue his dream of transforming medicine through technology, has combined his medical training, his specialization in artificial intelligence from Harvard, and his experience as founder of the software company Brainnovation to create a platform that promises to revolutionize aesthetic medicine and save lives.

"As a Colombian, I have always believed that Latinos have a unique capacity for innovation and resilience," said Dr. Cesar Velilla, Founder and CEO of MDGeniusAI. "I came to the United States with a dream: to use technology to make medicine safer and more accessible. Today, with MDGeniusAI, that dream is becoming a reality. This achievement is not just mine-it belongs to all the Latin American professionals who work tirelessly to make their mark on the world."
From Colombia to the Forefront of Healthcare AI

Dr. Velilla's story is a testament to Latino talent flourishing in the United States. After completing his medical training, Dr. Velilla became board-certified by the International Board of Cosmetic Surgery and founded Evolution MD, an aesthetic medicine practice that has become a benchmark in South Florida.
Recognizing the transformative potential of artificial intelligence, he completed Harvard's prestigious Executive Education Program in AI for Healthcare-training that gave him the tools to imagine and build MDGeniusAI. Previously, he had already demonstrated his entrepreneurial ability by founding Brainnovation, an AI software company.

"In Colombia, I learned the value of hard work and perseverance," reflects Dr. Velilla. "Those values, combined with the opportunities I found in the United States and the world-class training I received, allowed me to dream big. MDGeniusAI is the culmination of that journey."
An Unprecedented Innovation: 100% Built with AI
What makes MDGeniusAI unique is its fundamentally different architecture. While other companies have spent years adapting artificial intelligence to existing systems, Dr. Velilla made the bold decision to build an entirely new platform where AI is not an add-on-it is the very foundation of the system.

The platform integrates four revolutionary modules:
PICSTM (Postoperative Intelligence & Care System): The flagship module that can save lives, using voice analysis, image recognition, wearable device integration, and demographic risk algorithms to detect surgical complications before they become critical.
AURATM: Patient communication assistant with 24/7 support in English and Spanish.
NOVATM: Sales optimization engine with emotion detection, achieving conversion rates of 22-25% versus the 15% industry average.
PREP-AITM: Preoperative management system that automates patient preparation for surgery.

Global Impact: Technology That Saves Lives
MDGeniusAI's PICSTM module addresses a critical gap in patient safety. Current surgical risk calculators, designed for general surgery, demonstrate a 97% false-positive rate when applied to cosmetic surgery patients-an alarming statistic that Dr. Velilla is determined to change.
"Every complication we can prevent, every life we can save, makes all the effort worthwhile," states Dr. Velilla. "As a physician, my oath is first to do no harm. With MDGeniusAI, I am using technology to fulfill that oath in a way that was never before possible."

A $1.2 Trillion Dollar Market
MDGeniusAI is positioned to capture a significant portion of the healthcare CRM market, projected to grow from $10.64 billion in 2025 to $19.94 billion by 2034. The platform targets more than 660,000 healthcare providers in the United States, including aesthetic medicine, dental practices, mental health services, and cash-based medical specialties.
The PICSTM module alone addresses a post-operative monitoring market opportunity of more than $40 billion, with potential expansion to surgical specialties beyond cosmetic surgery.

A Message to the Latino Community
Dr. Velilla hopes his story will inspire other Latino professionals to pursue their dreams in technology and innovation.
"To all the young Colombians and Latin Americans who dream of making a difference in the world: the path is not easy, but it is possible. Our culture gives us strength, our education gives us tools, and our determination leads us to success. Don't let anyone tell you that you can't achieve something great. If I could do it, you can too."

Development Status and Opportunities
MDGeniusAI is currently in active development, with Evolution MD serving as the pilot environment. The company is seeking strategic partners, early adopters, and investors who share the vision of transforming aesthetic medicine through artificial intelligence.
The platform is being developed following FDA guidelines for Software as a Medical Device (SaMD), with HIPAA-compliant architecture.

About Dr. Cesar Velilla
Dr. Cesar Velilla is a Colombian physician, cosmetic surgeon board-certified by the International Board of Cosmetic Surgery, and founder of Evolution MD in South Florida. He completed Harvard's Executive Education Program in Artificial Intelligence for Healthcare and is the founder of Brainnovation, an AI software company. His trajectory represents the success of Latin American talent in the United States, combining medical excellence, technological innovation, and entrepreneurial spirit.

About MDGeniusAI
MDGeniusAI is a healthcare technology company headquartered in Miami, Florida, developing the first AI-native platform for aesthetic medicine and elective healthcare practices. Built 100% with artificial intelligence from inception, the company's vision is to create a comprehensive ecosystem that improves patient outcomes while increasing medical practice efficiency. MDGeniusAI is a testament to Latin American talent and innovation in the United States technology sector.

Media Contact:
MDGeniusAI Media Relations
848 Brickell Avenue, PH 5
Miami, Florida 33131
Phone: (305) 831-1120
press@mdgeniusai.com
www.mdgeniusai.com
For partnership and investment inquiries: invest@mdgeniusai.com
For interviews with Dr. Velilla: press@mdgeniusai.com

848 Brickell Avenue, PH5. Miami, fl 33131

MDGeniusAI is a healthcare technology company headquartered in Miami, Florida, developing the first AI-native platform for aesthetic medicine and elective healthcare practices. Built 100% with artificial intelligence from inception, the company's vision is to create a comprehensive ecosystem that improves patient outcomes while increasing medical practice efficiency. MDGeniusAI is a testament to Latin American talent and innovation in the United States technology sector.

This release was published on openPR.